Investment Q&A

Q: Is there something to replace WELL in the Healthcare sector in Canada or US, ETF inclued?

Q: Good Day All,

You recently answered a question on this company from another subscriber, and mentioned something about the cannabis sector. The way the answer was structured leaves me wondering about this remark as I don't believe CRRX operates in that sector; rather it provides drugs to seniors. Is the review of the fundamentals correct for the company, or are your comments based upon a different company in the cannabis sector? Could you clarify?

Q: VRNA Your opinion of this co. as a new investment?

Q: What do you think of this stock? Will it hold together (sorry, couldn't resist) Thx

Q: I am seriously considering pulling the trigger on this one to realize a substantial loss in my trading account. I also hold a position in my tsfa account and plan on riding this into 2023.
Your thoughts regarding taking the tax loss position at this time.
Thanks
Rick

Q: Are you concerned with ABBV debt to equity of 4.35? If not why? Thanks.

Q: Time to move on? Bought to target medical equipment at a reasonable valuation. Have full positions in ABBV and MRK and VHT for health care. Bought MDT thinking it would do well when medical procedures came back after coved. It was hit on diabetes and now earnings projections. Loosing patience. It is about the same price as 10 yrs ago. Im a value investor and like the dividend but need some growth. Suggestions.

Q: Good evening, 5i team.
I appreciate having your opinion on these 2 names in my RRSP: Gilead got to 52 week high recently and Medtronic was bought recently. Both have decent dividends and good potential.

Your thought on which one to keep if there is room only for 1. Thank you!

Q: Could I please your breakdown of RX recent earning report. Also, would you recommend Buy, Sell or Hold. Thanks … Cal

Q: Which US health insurer is your favourite for LT investment? If there is a different one that you all like, plse indicate and why.

Q: I bought TWST a few years ago, and have lost most of my investments in it. Would it be advisable to switch to LNTH.

Q: I hold these 3 healthcare stocks. Thinking of adding Lily. Do you see too much overlap in this combination or can you recommend others for diversification?

Thanks very much.

Mike

Q: Hello Peter,

We do not own LNTH as of yet but are watching the stock. When looking at sales and stock price for a 5-year period it was relatively flat. What event triggered a 3-fold increase in stock price? Was it one very large order for equipment in 2021 or a sustainable increase in equipment sales?

Cheers,
Debbie and Jerry

Q: I just sold off my Biogen holding and am looking for a replacement within the healthcare sector. I held Biogen for over 3 years and exited with a nice return, but I have to say that I did not enjoy the wild ride and price swings as it seemed to trade solely on its new Alzheimer’s drug advancements and setbacks. So now I am looking to replace it with something a little more stable but still with the expectation of slow and steady growth. What would be your top 1 or 2 picks be today for both the US and Canada that might fit. I already own Savaria and XLV so something besides these.

Q: Hi 5i
PFE ($49.36) has had a nice run. Any worries of a backlash against them as we all keep getting jabs and yet keep getting COVID? The virus mutates faster than they can come up with new vaccines. Will investors start to worry that this giant boost to revenue may disappear?
-And side question-how have your portfolios fared this year? Just curious since you don't own any Canadian stocks, have you managed to avoid major declines?

Greg

Q: Can you give me a couple of names of direct competitors to United Health.

Thanks Valter

Q: Hi 5i Team,
Pls give your assessment on Pfizer, this stock looks very cheap with a very low p/e and 3% plus dividend. what do you think of this company going forward, is it a buy, hold or sell?
Thank you for your help as always.

Q: Further to your response to an inquiry about Knight Therapeutic results, could you comment in any detail on management performance. They have been in charge for at least five years, the cash position is down from $800M to $145M {after buying GBT and company shares, etc.) and the stock price is down half from the $10 plus when Goodman brought them in and then disappeared.
I know he had an accident, but I saw him on BNN a couple of years ago and he looked fine, just made too much money on Paladin.
There just doesn't seem to be any drive to improve the company and increase shareholder value. Management seems unmotivated. Should Goodman replace them or sell the company to someone who can realize it's potential before I turn 100?
Thank youl.

Q: Hi Peter,

I will soon be receiving my pension funds from my ex-employer to put in my LIRA.
Can you suggest a few stocks with a decent upside....time frame 10-15 years.

Q: Please provide your comment on BHC's recent earnings report ?
Considering EPS of $ 1.10 the stock price seems cheap. I will appreciate your input on the valuation and high debt level.